SciELO - Scientific Electronic Library Online

 
vol.37 issue6Improvement of the knowledge on allergic cross-reactions between two drug groups: beta-lactams and NSAIDSRisk management at an Intensive Care Department: conciliation of medication author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Farmacia Hospitalaria

On-line version ISSN 2171-8695Print version ISSN 1130-6343

Abstract

MARTIN GONZALEZ, A.  and  ABAJO DEL ALAMO, C.. Electronic prescription for Primary Care: a reliable tool to conceal medication at hospital admission?. Farm Hosp. [online]. 2013, vol.37, n.6, pp.510-513. ISSN 2171-8695.  https://dx.doi.org/10.7399/FH.2013.37.6.751.

Objective: To analyze the reliability of an electronic prescription software at primary care (Medoracyl®) to conceal the medication at hospital admission. Method: Prospective, comparative study of the home-based validated treatment of patients admitted to the hospital as compared to the one prescribed through Medoracyl®. The medication at admission was gathered by medical interview, medical records, and revision of the medication brought by the patients; the medication active in Medoracyl® by consulting the application the admission day. The discrepancies between both therapies were analyzed. Results: 47 patients were included with 273 lines of home validated treatments and 274 lines of Medoracyl® treatment. 48 out of 273 lines were in discrepancy (17.6% [95% CI: 13.121.6]). 27 out of 48 were justified, whereas 7.8% represented a discrepancy risk [95% CI: 4.6-11.0]. Conclusions: Medoracyl® is a useful tool and easy to access that allows knowing more than 90% of the home medication of the patients.

Keywords : Conciliation; Discrepancies; Home treatment; Validation.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License